AbClon extends contract end date to Nov. 30 in corrected disclosure
AbClon corrected a voluntary disclosure for a single sales and supply contract, extending the end date to 2026-11-30. The contract value remains 424,056,300 won (9.0% of 2025 standalone revenue), covering reagent and lab equipment supply to South Korea’s National Institute of Food and Drug Safety Evaluation.